These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 27491038)

  • 1. Targeting Yes-associated Protein with Evolved Peptide Aptamers to Disrupt TGF-β Signaling Pathway: Therapeutic Implication for Bone Tumor.
    Ji WP; Dong Y
    Mol Inform; 2015 Nov; 34(11-12):771-7. PubMed ID: 27491038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of YAP WW1 domain-binding peptides to target TGFβ/BMP/Smad-YAP interaction in heterotopic ossification.
    Chen D; Liu S; Zhang W; Sun L
    J Pept Sci; 2015 Nov; 21(11):826-32. PubMed ID: 26435515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic profiling and identification of the peptide-mediated interactions between human Yes-associated protein and its partners in esophageal cancer.
    Chen F; Wang Q; Mu Y; Sun S; Yuan X; Shang P; Ji B
    J Mol Recognit; 2022 Mar; 35(3):e2947. PubMed ID: 34964176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of cyclic peptides to disrupt TGF-Β/SMAD7 signaling in heterotopic ossification.
    Zhong B; Zhang C; Guo S; Zhang C
    J Mol Graph Model; 2017 Mar; 72():25-31. PubMed ID: 28013146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WW domains of the yes-kinase-associated-protein (YAP) transcriptional regulator behave as independent units with different binding preferences for PPxY motif-containing ligands.
    Iglesias-Bexiga M; Castillo F; Cobos ES; Oka T; Sudol M; Luque I
    PLoS One; 2015; 10(1):e0113828. PubMed ID: 25607641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational derivation, extension, and cyclization of self-inhibitory peptides to target TGF-β/BMP signaling in ONFH.
    Zhu Z; Zhang C; Song W
    Amino Acids; 2017 Feb; 49(2):283-290. PubMed ID: 27826791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tankyrase Inhibitor Sensitizes Lung Cancer Cells to Endothelial Growth Factor Receptor (EGFR) Inhibition via Stabilizing Angiomotins and Inhibiting YAP Signaling.
    Wang H; Lu B; Castillo J; Zhang Y; Yang Z; McAllister G; Lindeman A; Reece-Hoyes J; Tallarico J; Russ C; Hoffman G; Xu W; Schirle M; Cong F
    J Biol Chem; 2016 Jul; 291(29):15256-66. PubMed ID: 27231341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.
    Zhou Z; Hu T; Xu Z; Lin Z; Zhang Z; Feng T; Zhu L; Rong Y; Shen H; Luk JM; Zhang X; Qin N
    FASEB J; 2015 Feb; 29(2):724-32. PubMed ID: 25384421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design and chemical modification of TEAD coactivator peptides to target hippo signaling pathway against gastrointestinal cancers.
    Gao S; Wang Y; Ji L
    J Recept Signal Transduct Res; 2021 Aug; 41(4):408-415. PubMed ID: 32912021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based derivation and optimization of YAP-like coactivator-derived peptides to selectively target TEAD family transcription factors by hydrocarbon stapling and cyclization.
    He B; Wu T; He P; Lv F; Liu H
    Chem Biol Drug Des; 2021 Jun; 97(6):1129-1136. PubMed ID: 33283479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquiritigenin inhibits hepatic fibrogenesis and TGF-β1/Smad with Hippo/YAP signal.
    Lee EH; Park KI; Kim KY; Lee JH; Jang EJ; Ku SK; Kim SC; Suk HY; Park JY; Baek SY; Kim YW
    Phytomedicine; 2019 Sep; 62():152780. PubMed ID: 31121384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational Design and Intramolecular Cyclization of Hotspot Peptide Segments at YAP-TEAD4 Complex Interface.
    Zhang D; He D; Pan X; Liu L
    Protein Pept Lett; 2020; 27(10):999-1006. PubMed ID: 32286937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA.
    Zhao BM; Hoffmann FM
    Mol Biol Cell; 2006 Sep; 17(9):3819-31. PubMed ID: 16775010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance.
    Wang DY; Wu YN; Huang JQ; Wang W; Xu M; Jia JP; Han G; Mao BB; Bi WZ
    Chin J Cancer; 2016 May; 35():47. PubMed ID: 27206784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4.
    Li Y; Liu S; Ng EY; Li R; Poulsen A; Hill J; Pobbati AV; Hung AW; Hong W; Keller TH; Kang C
    Biochem J; 2018 Jun; 475(12):2043-2055. PubMed ID: 29760238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ.
    Mesrouze Y; Meyerhofer M; Bokhovchuk F; Fontana P; Zimmermann C; Martin T; Delaunay C; Izaac A; Kallen J; Schmelzle T; Erdmann D; Chène P
    Protein Sci; 2017 Dec; 26(12):2399-2409. PubMed ID: 28960584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design of potent linear peptide inhibitors of the YAP-TEAD protein-protein interaction derived from the YAP omega-loop sequence.
    Furet P; Salem B; Mesrouze Y; Schmelzle T; Lewis I; Kallen J; Chène P
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2316-2319. PubMed ID: 31235263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Cthrc1 Activates Normal Fibroblasts and Suppresses Keloid Fibroblasts by Inhibiting TGF-β/Smad Signal Pathway and Modulating YAP Subcellular Location.
    Zhao MJ; Chen SY; Qu XY; Abdul-Fattah B; Lai T; Xie M; Wu SD; Zhou YW; Huang CZ
    Curr Med Sci; 2018 Oct; 38(5):894-902. PubMed ID: 30341526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review.
    Crawford JJ; Bronner SM; Zbieg JR
    Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.